stemcell
The Niche

The Niche

Knoepfler lab stem cell blog

  • Home
  • Contact
  • About Us
  • Trial search
  • Treatments
  • Report a clinic
  • RMAT List (37)
  • TED talk
  • Nature
  • Privacy
  • Stem Cell Book
  • Dragon book
  • 2019 Meetings
  • 2020 Meetings
  • Stem cells in your language
No Picture

I Hate Your Paper: Dr. No and the Editors that are ruining Peer Review

August 5, 2010 Paul Knoepfler 0

The Scientist has a few pieces out on the trouble with peer review including my personal favorite: I Hate Your Paper. That article rings so true as do the quotes from the scientists. Peer review in the stem cell field and […]

No Picture

Five simple ways to protect your stem cells and your health

August 3, 2010 Paul Knoepfler 0

Regenerative medicine is very exciting. But what’s even better than regenerative medicine? Preventative medicine. If one can prevent a problem for occurring in the first place, it is far better than trying to treat it after the fact. Of course […]

No Picture

Advice for new PIs part I: start before you start

August 2, 2010 Paul Knoepfler 0

It’s an exciting feeling coming into a new lab as a new professor. An empty lab has so much potential and one can imagine how one’s lab will look in the future. I walked into my lab in 2006 (see […]

No Picture

Tumorigenicity and Pluripotency teased apart? Not yet for Myc

August 2, 2010 Paul Knoepfler 0

A paper just came out in PNAS entitled “Promotion of direct reprogramming by transformation-deficient Myc”. The main thrust of this paper is that the tumorigenic and pluripotency-related functions of Myc could be separated. It focused primarily on the lesser studied […]

No Picture

Striking iPS cell research publishing trends: what do they mean?

August 1, 2010 Paul Knoepfler 0

The young iPS cell field has published a truly massive number of papers in just 4 years. Searching ISI Web of Knowledge for papers with titles reflecting iPS cell research (not just those that mention iPS cells), we find 424 […]

Posts navigation

« 1 … 473 474 475 »

The mission of the Knoepfler Lab Blog here at UC Davis School of Medicine is to build stem cell bridges to new treatments and cures through education, outreach, and science.

I encourage readers of this blog to make comments.

There are some rules and key considerations for ipscell.com governing the comments to keep in mind.

  • Comments will be moderated by a really busy human being so they may not appear right away, particularly if they are very long and/or contain allegations against people or companies, or express inflammatory opinions in which case they may take up to a day or even longer to appear or may never appear.
  • Comments cannot include personal attacks.
  • Commenters should avoid being libelous to a person or corporation.
  • Commenters must use a valid email address.
  • Commenters generally cannot promote a specific unproven stem cell clinic or physician even by implication.
  • Commenters are solely responsible for the content of their comments.
  • I generally do not post comments written by parties referring to other parties who are both involved in an ongoing or pending legal dispute with each other such as litigation. Exceptions to this may be allowed for comments on a blog post that has a topic focused specifically on said legal disputes.
  • Commenters cannot give medical advice.
  • Consumers posting comments regarding their opinions of medical treatment they received are solely responsible for that content and readers should understand that such comments reflect opinions, not facts.
  • Commenters who violate this policy with their submitted comments may temporarily or permanently lose the right to make comments.

By submitting your comment for potential posting on this blog you agree that the comment may be either edited or not posted at all at the blog's discretion if there is concern about non-compliance with this comment policy.

Disclosures

The views expressed on this blog in posts are my own and do not reflect the views of my employer, UC Davis.

I have no financial interests in any stem cell companies or patents in that area.

No material on this website should be considered medical advice and all medical decisions should be discussed with your personal physician first.

Subscribe to this Blog

Join 24,195 other subscribers

Paul KnoepflerFollow

Prof @UCDAVIS Stem cells & Kids Brain Cancer Epigenomics #CRISPR Science policy/ethics. #scicomm TED https://t.co/4XhF0V5XiZ New book on making dragons🐲https://t.co/q9ezUzZdtx

Paul Knoepfler
pknoepflerPaul Knoepfler@pknoepfler·
8h

Wow, Liveyon has stopped sales of unproven umbilical cord cells after FDA warning letter
@lauriemcginley2
https://washingtonpost.com/health/2019/12/13/california-stem-cell-company-halts-sales-after-fda-warning/ Here's my take on that warning letter & other recent FDA steps https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ I bet @BadBatchWondery podcast also played a role #stemcells

Reply on Twitter 1205609226476777474Retweet on Twitter 12056092264767774744Like on Twitter 12056092264767774745Twitter 1205609226476777474
pknoepflerPaul Knoepfler@pknoepfler·
8h

Bizarro cartoons often have me thinking of sketchy stem cell clinics, when they really having nothing to do with that. #stemcells Have Friday #TGIF

2
Reply on Twitter 1205598971860680704Retweet on Twitter 1205598971860680704Like on Twitter 12055989718606807044Twitter 1205598971860680704
james_jamstewJames Stewart@james_jamstew·
13 Dec

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms https://ipscell.com/2019/12/fda-spike-clinic-supplier-liveyon-warning-letter-notice-on-exosome-harms/ via @pknoepfler

Reply on Twitter 1205280468796526592Retweet on Twitter 12052804687965265922Like on Twitter 12052804687965265923Twitter 1205280468796526592
Load More...
  • RSS - Posts
  • RSS - Comments

Recent Comments

  • Paul Knoepfler on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Bill Jones on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Miss Matadora on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms
  • Matthew Wilgo on FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

Copyright © 2019 | Knoepfler Lab Stem Cell Blog, UC Davis, 1 Shields Ave, Davis, CA 95616. Designwork by Tradesouthwest Top